Genetic Engineering & Biotechnology News

MAY15 2017

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link:

Contents of this Issue


Page 27 of 37

26 | MAY 15, 2017 | | Genetic Engineering & Biotechnology News Translational Medicine Feature Roundup Clinicians are starting to become aware of the advantages of liquid biopsy, but they still have reservations. The point is, clinicians are unlikely to be moved by superficial appeals to technological progress. They will not fully accept liquid biopsy until they see substantive demonstrations that the sample-collecting method offers unique benefits to patients, without depriving them of any of the benefits that are already available with traditional biopsy techniques. Granted, liquid biopsy and traditional biopsy are not mutually exclusive. It is striking, however, that several of the liquid biopsy experts in this roundup editorial said the same thing: Clinicians are looking for assurances that liquid biopsy and traditional biopsy demonstrate concordance. This requirement seems to have the status of a "necessary but not sufficient" condition. GEN interviewed a number of liquid biopsy experts to learn more about the status of liquid biopsies in the clinic and what they view as some long-term goals for this promising technology. Liquid Biopsies Remain Wait and See For Some Clinicians E X P E R T P A N E L Peggy Robinson U.S. Vice President Angle Viresh Patel, Ph.D. Global Marketing Director, Digital Biology Group Bio-Rad Laboratories Cristian Ionescu- Zanetti, Ph.D. Chief Technology Officer and Co-Founder Fluxion Biosciences Brian Burke, Ph.D. Head of Commercial Business Management Horizon Discovery Nicolò Manaresi Ph.D. Chief Scientific Officer and Co-Founder Menarini Silicon Biosystems C. Jimmy Lin, M.D., Ph.D. Chief Scientific Officer Oncology Natera Michael Kazinski Senior Director Molecular Preanalytical Technologies Qiagen Kelli Bramlett Director, R&D Clinical Next Generation Sequencing Thermo Fisher Scientific 26 | MAY 15, 2017 | | Genetic Engineering & Biotechnology News

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - MAY15 2017